IRIS
COSTANZO, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.076
EU - Europa 1.410
AS - Asia 412
AF - Africa 225
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 14
SA - Sud America 12
Totale 10.164
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.016
FI - Finlandia 369
IE - Irlanda 319
CN - Cina 290
NG - Nigeria 223
DE - Germania 145
FR - Francia 141
IT - Italia 99
NL - Olanda 94
GB - Regno Unito 65
SE - Svezia 55
CA - Canada 53
BE - Belgio 43
IN - India 35
TR - Turchia 28
IL - Israele 23
RU - Federazione Russa 18
A2 - ???statistics.table.value.countryCode.A2??? 11
UA - Ucraina 11
AU - Australia 9
RO - Romania 9
CL - Cile 7
ES - Italia 7
MX - Messico 7
HK - Hong Kong 6
NZ - Nuova Zelanda 6
JO - Giordania 5
DK - Danimarca 4
IR - Iran 4
KR - Corea 4
MD - Moldavia 4
RS - Serbia 4
BG - Bulgaria 3
BR - Brasile 3
CH - Svizzera 3
EU - Europa 3
GR - Grecia 3
JP - Giappone 3
NO - Norvegia 3
PT - Portogallo 3
SG - Singapore 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
PL - Polonia 2
BD - Bangladesh 1
EC - Ecuador 1
EG - Egitto 1
HU - Ungheria 1
ID - Indonesia 1
IM - Isola di Man 1
IQ - Iraq 1
KW - Kuwait 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MY - Malesia 1
PE - Perù 1
TH - Thailandia 1
TN - Tunisia 1
Totale 10.164
Salva come PNG Salva come JPEG
Città #
Chandler 1.695
Wilmington 1.445
San Mateo 575
Ann Arbor 453
Helsinki 369
Ashburn 338
Dublin 319
Boardman 292
Shanghai 278
Lawrence 261
Princeton 261
Leawood 259
Benin City 223
New York 187
Fairfield 146
Woodbridge 131
Paris 126
Amsterdam 84
London 57
Toronto 43
San Diego 41
Seattle 41
Brussels 40
Falls Church 33
Phoenix 31
Kocaeli 28
Milan 26
Norwalk 24
Houston 19
Redmond 16
Falkenstein 12
Moscow 11
Dallas 10
Chennai 9
Des Moines 9
Dronten 8
Duncan 8
Abbiategrasso 7
Hanover 7
Cambridge 6
Florence 6
Monmouth Junction 6
Newark 6
Pune 6
Redwood City 6
Amman 5
Clearwater 5
Andover 4
Chicago 4
Chisinau 4
Esbjerg 4
Genoa 4
Rome 4
Aguascalientes 3
Auckland 3
Bergamo 3
Berlin 3
Catania 3
Collegeville 3
Dunedin 3
Frankfurt am Main 3
Henderson 3
Kemerovo 3
Monterrey 3
Ottawa 3
Pavia 3
San Francisco 3
Taipei 3
Tappahannock 3
Winnipeg 3
Apo 2
Athens 2
Beijing 2
Chieti 2
Gunzenhausen 2
Kochi 2
Las Vegas 2
Logan 2
Longueville 2
Nancy 2
Naples 2
Sacramento 2
Santa Coloma de Gramenet 2
Smederevo 2
Spoltore 2
Susquehanna 2
São Paulo 2
Thyez 2
Tokyo 2
Valencia 2
Zhengzhou 2
Alexandria 1
Bangkok 1
Basra 1
Belgrade 1
Biandronno 1
Bielefeld 1
Bollebygd 1
Brampton 1
Brierley Hill 1
Totale 8.094
Salva come PNG Salva come JPEG
Nome #
Living with Chronic Spontaneous Urticaria in Italy: A Narrative Medicine Project to Improve the Pathway of Patient Care 297
CD28 costimulation regulates FOXP3 in a RelA/NF-κB-dependent mechanism. 114
y Clinical similarity of the biosimilar ABP 501 compared with adalimumab after single transition: long-term results from a randomized controlled, double-blind, 52-week, phase III trial in patients with moderate-to-severe plaque psoriasis 83
Rosacea-like Acute Reaction After Hyaluronic Acid Dermal Filler 81
IL-21 in the pathogenesis and treatment of skin diseases. 61
Herpes simplex virus disrupts NF-kappa B regulation by blocking its recruitment on the I kappa B alpha promoter and directing the factor on viral genes 61
Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis 59
Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes. 59
FGF8, c-Abl and p300 participate in a pathway that controls stability and function of the Delta Np63 alpha protein 58
Actinic keratosis treated with an immune response modifier: a case report of six patients 57
How to make a skin-tight dress: the p63/claudin-1 connection 56
p63 induces key target genes required for epidermal morphogenesis 55
Noninferiority of biosimilar MSB110222 to reference adalimumab for chronic plaque psoriasis 55
Topical use of valproic acid for the prevention or treatment of skin disorders 55
Specific Infiltrate of Hodgkin Lymphoma at Site of Cellulitis Mimicking Secondary Cutaneous Involvement 55
Additional complexity in p73: induction by mitogens in lymphoid cells and identification of two new splicing variants epsilon and zeta 54
Brodalumab: a new way to inhibit IL-17 in psoriasis 53
High-dose intravenous immunoglobulin for severe drug reactions: Efficacy in toxic epidermal necrolysis 53
Adalimumab for severe psoriasis and psoriatic arthritis: An open-label study in 30 patients previously treated with other biologics 53
CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappa B subunits on IL-8 and Bcl-xL gene promotors 52
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 52
Keratosis punctata palmoplantaris and malignancies: Case report 52
Psychiatric comorbidity and suicidal ideation in psoriasis, melanoma and allergic disorders 52
'Living with chronic urticaria': a study through narrative medicine to improve the quality of care 52
The p53/p63/p73 family of transcription factors: overlapping and distinct functions. . 2000 May;113 ( Pt 10):1661-70 51
Zosteriform metastasis of occult bronchogenic carcinoma. 51
Ashy dermatosis: clinico-pathological associations in two cases] 51
Adalimumab for the treatment of severe psoriasis and psoriatic arthritis 50
Psoriasis: from pathogenesis to novel therapeutic approaches. 50
Biomarkers to optimize ustekinumab therapy in psoriatic patients 50
Histone deacetylases as new therapeutical targets for the treatment of Non-Melanoma Skin Cancer: results of phase I/IIa trial with topical DAC060 50
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy 49
A feedback regulatory loop between p63 and Dlx3: implications for epidermal differentiation 49
Clinical similarity of biosimilar ABP 501 to adalimumab in the treatment of patients with moderate to severe plaque psoriasis: A randomized, double-blind, multicenter, phase III study 49
Safety and efficacy study on etanercept in patients with plaque psoriasis 49
A p38-dependent pathway regulates DNp63 DNA binding to p53 dependent promoters in UV-induced apoptosis of keratinocytes 49
Role of p63 in keratinocyte differentiation and proliferation 49
Treatment of psoriasis and psoriatic arthritis. 48
Clinical applications of methyl aminolevulinate photodynamic therapy (MAL-PDT) for the treatment of non melanoma-skin cancers 48
Elementi di dermatologia 48
Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody. 47
Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris. 47
A p38-dependent pathway regulates Delta Np63 DNA binding to p53-dependent promoters in UV-induced apoptosis of keratinocytes 47
Long-term treatment with adalimumab in psoriatic arthritis: serum adalimumab concentration, immunogenicity and the link with clinical response 47
Adalimumab for severe psoriasis and psoriatic arthritis: an open label study in 30 patients previously treated with other biologics 47
Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway 47
Prevalence and genomic variability of transfusion transmitted virus in Italian cryptogenic chronic liver disease and healthy blood donors. 47
A role for the p63-IKKalpha pathway in the development of ectodermal dysplasias 47
RelA/NF-kappaB recruitment on the bax gene promoter antagonizes p73-dependent apoptosis in costimulated T cells 46
IKKalpha downregulation in psoriasis: New insights in the pathway regulating keratinocyte proliferation 46
Programmed cell death in the skin 46
Professor Sergio Chimenti: 1949-2016 46
Induction of the DNA-binding activity of c-jun/c-fos heterodimers by the hepatitis B virus transactivator pX. 46
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis 46
HLA-C*06 and response to ustekinumab in Caucasian patients with psoriasis: Outcome and long-term follow-up 45
Long-term safety of etanercept in psoriasis: Retrospective study focused on infections 45
Age and gender influence on HIDRAdisk outcomes in adalimumab-treated hidradenitis suppurativa patients 45
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target. 44
Delta Np63 knockdown mice: a mouse model for AEC syndrome 44
Role of the HLA-C(star)06 allele in clinical response to ustekinumab: evidence from real life in a large cohort of European patients 44
Different applications of monochromatic excimer light in skin diseases 44
A myogenic differentiation checkpoint activated by genotoxic stress 44
Tumor necrosis factor (TNF) receptor 1 signaling downstream of TNF receptor-associated factor 2. Nuclear factor kappaB (NFkappaB)-inducing kinase requirement for activation of activating protein 1 and NFkappaB but not of c-Jun N-terminal kinase/stress-activated protein kinase 44
Structure, function and regulation of p63 and p73. . 1999 Dec;6(12):1146-53 44
IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis 44
p63 and p73 transactivate differentiation gene promoters in human keratinocytes 44
Two new p73 splice variants, gamma and delta, with different transcriptional activity 43
c-E10 is a caspase-recruiting domain-containing protein that interacts with components of death receptors signaling pathway and activates nuclear factor-kappaB 43
Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling 43
DNp73 alpha protects myogenic cells from apoptosis. 43
Infection of circulating and liver infiltrating T cells by hepatitis C virus of different subtypes. 43
The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis. 43
p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis 43
Label-free and non-invasive discrimination of HaCaT and melanoma cells in a co-culture model by hyperspectral confocal reflectance microscopy 43
HLA‐C*06 and psoriasis: susceptibility, phenotype, course and response to treatment 43
Patient-relevant needs and treatment goals in nail psoriasis. 43
HLACw6 predisposes to clinical response to IL12/23 blocker ustekinumab: Results of short- and long-term treatment in anti-TNF naive patients 43
Dermatophytosis Caused by Trichophyton verrucosum in an Immunosuppressed Patient: Successful Outcome with Terbinafine 43
Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy 43
p63-dependent and independent mechanisms of nectin-1 and -4 regulation in the epidermis. 42
Living Matter Observations with a Novel Hyperspectral Supercontinuum Confocal Microscope for VIS to Near-IR Reflectance Spectroscopy 42
Adenosine deaminase, a key enzyme in DNA precursors control, is a new p73 target 42
No metagenomic evidence of tumorigenic viruses in cancers from a selected cohort of immunosuppressed subjects 42
Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA. 42
Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope 42
Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab 42
A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naive patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial 42
Trichostatin A up-regulates p73 and induces Bax-dependent apoptosis in cisplatin-resistant ovarian cancer cells 41
TRIM8 and p53: making the right decision. 41
The p73 gene is an anti-tumoral target of the RAR beta/gamma-selective retinoid tazarotene 41
Induction of gene expression via activator protein-1 in the ascorbate protection against UV-induced damage. 41
DLX5, FGF8 and the Pin1 isomerase control ΔNp63α protein stability during limb development: a regulatory loop at the basis of the SHFM and EEC congenital malformations. 41
A role of p73 in mitotic exit 41
Nuclear factor kB-independent cytoprotective pathways originating at tumor necrosis factor receptor-associated factor 2 41
Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey 41
Fas/Apo1 mutations and autoimmune lymphoproliferative syndrome in a patient with type 2 autoimmune hepatitis. Gastroenterology. 1997 Oct;113(4):1384-9 41
The impact of COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biologic therapy: the Northern Italy experience. 40
Maturation of intermediate cells into spinous cells during skin development requires induction of IKK alpha by Delta Np63 alpha 40
Anziano e dermatologia 40
Diagnosis and management of moderate to severe adult atopic dermatitis: a Consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC), and the Italian Society of Allergological, Environmental and Occupational Dermatology (SIDAPA) 40
Totale 5.077
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.496
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.496
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 0 0 0 0 0 0 0 0 7
2020/20212.668 25 84 31 14 23 803 361 188 504 358 3 274
2021/20221.472 49 12 19 323 21 38 57 195 143 111 413 91
2022/20234.235 595 166 374 543 399 390 5 353 790 319 242 59
2023/20241.985 158 237 592 68 54 222 174 416 44 20 0 0
Totale 10.367